134 related articles for article (PubMed ID: 24362914)
1. Tumor suppressor VHL functions in the control of mitotic fidelity.
Hell MP; Duda M; Weber TC; Moch H; Krek W
Cancer Res; 2014 May; 74(9):2422-31. PubMed ID: 24362914
[TBL] [Abstract][Full Text] [Related]
2. VHL loss causes spindle misorientation and chromosome instability.
Thoma CR; Toso A; Gutbrodt KL; Reggi SP; Frew IJ; Schraml P; Hergovich A; Moch H; Meraldi P; Krek W
Nat Cell Biol; 2009 Aug; 11(8):994-1001. PubMed ID: 19620968
[TBL] [Abstract][Full Text] [Related]
3. miR-28-5p promotes chromosomal instability in VHL-associated cancers by inhibiting Mad2 translation.
Hell MP; Thoma CR; Fankhauser N; Christinat Y; Weber TC; Krek W
Cancer Res; 2014 May; 74(9):2432-43. PubMed ID: 24491803
[TBL] [Abstract][Full Text] [Related]
4. The VHL tumor suppressor in development and disease: functional studies in mice by conditional gene targeting.
Haase VH
Semin Cell Dev Biol; 2005; 16(4-5):564-74. PubMed ID: 15908240
[TBL] [Abstract][Full Text] [Related]
5. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
6. Von hippel-lindau: a tumor suppressor links microtubules to ciliogenesis and cancer development.
Kuehn EW; Walz G; Benzing T
Cancer Res; 2007 May; 67(10):4537-40. PubMed ID: 17510376
[TBL] [Abstract][Full Text] [Related]
7. Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice.
Albers J; Rajski M; Schönenberger D; Harlander S; Schraml P; von Teichman A; Georgiev S; Wild PJ; Moch H; Krek W; Frew IJ
EMBO Mol Med; 2013 Jun; 5(6):949-64. PubMed ID: 23606570
[TBL] [Abstract][Full Text] [Related]
8. The von Hippel-Lindau tumor suppressor gene and kidney cancer.
Kaelin WG
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6290S-5S. PubMed ID: 15448019
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinoma.
Turcotte S; Desrosiers RR; Beliveau R
Am J Physiol Renal Physiol; 2004 Feb; 286(2):F338-48. PubMed ID: 14583436
[TBL] [Abstract][Full Text] [Related]
10. Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma.
Luu VD; Boysen G; Struckmann K; Casagrande S; von Teichman A; Wild PJ; Sulser T; Schraml P; Moch H
Clin Cancer Res; 2009 May; 15(10):3297-304. PubMed ID: 19401348
[TBL] [Abstract][Full Text] [Related]
11. von Hippel-Lindau tumor suppressor protein regulates the assembly of intercellular junctions in renal cancer cells through hypoxia-inducible factor-independent mechanisms.
Calzada MJ; Esteban MA; Feijoo-Cuaresma M; Castellanos MC; Naranjo-Suárez S; Temes E; Méndez F; Yánez-Mo M; Ohh M; Landázuri MO
Cancer Res; 2006 Feb; 66(3):1553-60. PubMed ID: 16452212
[TBL] [Abstract][Full Text] [Related]
12. pVHL co-ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear-cell renal cell carcinoma.
Struckmann K; Mertz K; Steu S; Storz M; Staller P; Krek W; Schraml P; Moch H
J Pathol; 2008 Mar; 214(4):464-71. PubMed ID: 18189328
[TBL] [Abstract][Full Text] [Related]
13. JunB promotes cell invasion and angiogenesis in VHL-defective renal cell carcinoma.
Kanno T; Kamba T; Yamasaki T; Shibasaki N; Saito R; Terada N; Toda Y; Mikami Y; Inoue T; Kanematsu A; Nishiyama H; Ogawa O; Nakamura E
Oncogene; 2012 Jun; 31(25):3098-110. PubMed ID: 22020339
[TBL] [Abstract][Full Text] [Related]
14. Regulation of receptor for activated C kinase 1 protein by the von Hippel-Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasiveness.
He X; Wang J; Messing EM; Wu G
Oncogene; 2011 Feb; 30(5):535-47. PubMed ID: 20871634
[TBL] [Abstract][Full Text] [Related]
15. Treatment of kidney cancer: insights provided by the VHL tumor-suppressor protein.
Kaelin WG
Cancer; 2009 May; 115(10 Suppl):2262-72. PubMed ID: 19402056
[TBL] [Abstract][Full Text] [Related]
16. VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel-Lindau disease.
Montani M; Heinimann K; von Teichman A; Rudolph T; Perren A; Moch H
Am J Surg Pathol; 2010 Jun; 34(6):806-15. PubMed ID: 20431476
[TBL] [Abstract][Full Text] [Related]
17. Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma.
Perier A; Fregni G; Wittnebel S; Gad S; Allard M; Gervois N; Escudier B; Azzarone B; Caignard A
Oncogene; 2011 Jun; 30(23):2622-32. PubMed ID: 21258414
[TBL] [Abstract][Full Text] [Related]
18. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
[TBL] [Abstract][Full Text] [Related]
19. The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent antiapoptotic pathway.
Qi H; Ohh M
Cancer Res; 2003 Nov; 63(21):7076-80. PubMed ID: 14612498
[TBL] [Abstract][Full Text] [Related]
20. Von Hippel-Lindau gene product directs cytokinesis: a new tumor suppressor function.
Sinha S; Mondal G; Hwang EJ; Han da W; Dutta SK; Iyer S; Karumanchi SA; Kim KI; Couch FJ; Mukhopadhyay D
J Cell Sci; 2011 Jul; 124(Pt 13):2132-42. PubMed ID: 21652636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]